Is gender bias an invisible barrier to equitable cancer care?
Ipsos UK blog about their report into gender bias in cancer care in the UK and some of the causes behind it.
News
Blog
- Information and adviceEducation and awareness
-
Education and awareness
- Education
-
- Tips for you
-
ResearchBlog
New Rare Gynae Cancer Fund project: Developing a test to diagnose uterine sarcoma
Thanks to your support of our Rare Gynae Cancer Fund, we have awarded a grant to Dr Esther Moss at the University of Leicester and NIHR Leicester Biomedical Research Centre, to develop a blood test to diagnose uterine sarcoma.
‘From Grief to Love’ a book covering 4,300-miles
We hear about his emotional journey, from the grief at the loss of his wife from cervical cancer to his healing through this epic journey.
‘I am determined to see a future where the experiences I had are no longer the reality.’
Emma joined us at the “Reception to celebrate Scotland’s progress towards eliminating cervical cancer” convened by MSD with support from The Eve Appeal. She shared her story of her cervical cancer diagnosis and advocacy work.
Scotland racing towards cervical cancer elimination
Our CEO, Athena, blogs about what is needed to reach our goal of eliminating cervical cancer.
Research news: Second Eve Fellowship to try detect ovarian cancer in the early stages
This fellowship aims to create a new blood test to detect ovarian cancer at its earliest stages when it is most treatable.
We have a fresh new look
Over the past 22 years, with the support of our community, we have been working hard to save lives from gynaecological cancers.
NewsBlogWhat you need to know about menopause and HRT
Yesterday, a Panorama episode aired on BBC- The Menopause Industry Uncovered.
‘It is so important to know what things look and feel like and to know your normal.’
Helen shares her experience of her vulval cancer diagnosis for Gynae Cancer Awareness Month.
Stay in touch
Sign up to receive emails and get the latest news from The Eve Appeal.
You can view our privacy policy here.